Advanced search
Publication Cover
Acta Oncologica Volume 53, 2014 - Issue 7
Journal homepage
2,404
Views
24
CrossRef citations to date
0
Altmetric
Brain tumours

Neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed glioblastoma multiforme: A randomized phase II study

Kenneth F. HoflandDepartment of Oncology and Radiotherapy, Rigshospitalet, Copenhagen, DenmarkCorrespondence[email protected]
,
Steinbjørn HansenDepartment of Oncology, Odense University Hospital, Odense
,
Morten SorensenDepartment of Oncology and Radiotherapy, Rigshospitalet, Copenhagen, Denmark
,
Silke EngelholmDepartment of Oncology and Radiotherapy, Rigshospitalet, Copenhagen, Denmark
,
Henrik P. SchultzDepartment of Oncology, Aarhus University Hospital, Denmark
,
Aida MuhicDepartment of Oncology and Radiotherapy, Rigshospitalet, Copenhagen, Denmark
,
Kirsten GrunnetDepartment of Radiation Biology, Rigshospitalet, Copenhagen, Denmark
,
Anders AskDepartment of Oncology and Radiotherapy, Rigshospitalet, Copenhagen, Denmark
,
Junia C. CostaDepartment of Oncology and Radiotherapy, Rigshospitalet, Copenhagen, Denmark
,
Charlotte KristiansenDepartment of Oncology, Odense University Hospital, Odense
,
Carsten ThomsenDepartment of Radiology, Rigshospitalet, Copenhagen, Denmark
,
Hans Skovgaard PoulsenDepartment of Oncology and Radiotherapy, Rigshospitalet, Copenhagen, Denmark;Department of Radiation Biology, Rigshospitalet, Copenhagen, Denmark
&
Ulrik LassenDepartment of Oncology and Radiotherapy, Rigshospitalet, Copenhagen, Denmark
 show all
Pages 939-944 | Received 11 Jul 2013, Accepted 20 Dec 2013, Published online: 23 Jan 2014

Citations (24)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Hans Skovgaard Poulsen, Thomas Urup, Signe Regner Michaelsen, Mikkel Staberg, Mette Villingshøj & Ulrik Lassen. (2014) The impact of bevacizumab treatment on survival and quality of life in newly diagnosed glioblastoma patients. Cancer Management and Research 6, pages 373-387.
Read now

Articles from other publishers (23)

Timothy Johanssen, Laura McVeigh, Sara Erridge, Geoffrey Higgins, Joelle Straehla, Margaret Frame, Tero Aittokallio, Neil O. Carragher & Daniel Ebner. (2023) Glioblastoma and the search for non-hypothesis driven combination therapeutics in academia. Frontiers in Oncology 12.
Crossref
Ahmad Daher & Santosh Kesari. 2023. New Insights Into Glioblastoma. New Insights Into Glioblastoma 285 317 .
Nimish A Mohile, Hans Messersmith, Na Tosha N Gatson, Andreas F Hottinger, Andrew B Lassman, Jordan Morton, Douglas Ney, Phioanh Leia Nghiemphu, Adriana Olar, Jeffery Olson, James Perry, Jana Portnow, David Schiff, Anne Shannon, Helen A Shih, Roy Strowd, Martin van den Bent, Mateo Ziu & Jaishri Blakeley. (2022) Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline. Neuro-Oncology 24:3, pages 358-383.
Crossref
Nimish A. Mohile, Hans Messersmith, Na Tosha Gatson, Andreas F. Hottinger, Andrew Lassman, Jordan Morton, Douglas Ney, Phioanh Leia Nghiemphu, Adriana Olar, Jeffery Olson, James Perry, Jana Portnow, David Schiff, Anne Shannon, Helen A. Shih, Roy Strowd, Martin van den Bent, Mateo Ziu & Jaishri Blakeley. (2021) Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline. Journal of Clinical Oncology.
Crossref
Beatrice Detti, Silvia Scoccianti, Maria Ausilia Teriaca, Virginia Maragna, Victoria Lorenzetti, Sara Lucidi, Chiara Bellini, Daniela Greto, Isacco Desideri & Lorenzo Livi. (2021) Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients. La radiologia medica 126:9, pages 1249-1254.
Crossref
Julie Bolcaen, Shankari Nair, Cathryn Driver, Tebatso Boshomane, Thomas Ebenhan & Charlot Vandevoorde. (2021) Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma. Pharmaceuticals 14:7, pages 626.
Crossref
Javier A. Jacobo, Sonia Mejia-Perez & Sergio Moreno-Jimenez. (2021) The Role of Neoadjuvant Therapy to Improve the Extent of Resection in “Unresectable” Gliomas. World Neurosurgery 146, pages 53-58.
Crossref
Navid Redjal, Brian V. Nahed, Jorg Dietrich, Steven N. Kalkanis & Jeffrey J. Olson. (2020) Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of chemotherapeutic management and antiangiogenic treatment of newly diagnosed glioblastoma in adults. Journal of Neuro-Oncology 150:2, pages 165-213.
Crossref
Lina Marenco-Hillembrand, Olindi Wijesekera, Paola Suarez-Meade, David Mampre, Christina Jackson, Jennifer Peterson, Daniel Trifiletti, Julie Hammack, Kyle Ortiz, Elizabeth Lesser, Matthew Spiegel, Calder Prevatt, Maria Hawayek, Alfredo Quinones-Hinojosa & Kaisorn L. Chaichana. (2020) Trends in glioblastoma: outcomes over time and type of intervention: a systematic evidence based analysis. Journal of Neuro-Oncology 147:2, pages 297-307.
Crossref
Catherine Hanna, Theresa A Lawrie, Ewelina Rogozińska, Ashleigh Kernohan, Sarah Jefferies, Helen Bulbeck, Usama M Ali, Tomos Robinson & Robin Grant. (2020) Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis. Cochrane Database of Systematic Reviews 2020:3.
Crossref
Jiawei Dong, Xiangqi Meng, Siyi Li, Qun Chen, Lei Shi, Chuanlu Jiang & Jinquan Cai. (2019) Risk of Adverse Vascular Events in Patients with Malignant Glioma Treated with Bevacizumab Plus Irinotecan: A Systematic Review and Meta-Analysis. World Neurosurgery 130, pages e236-e243.
Crossref
Daniel H. Schanne, Anca-L. Grosu & Dan G. Duda. 2019. Tumor Angiogenesis. Tumor Angiogenesis 349 358 .
Signe Regner Michaelsen, Thomas Urup, Lars Rønn Olsen, Helle Broholm, Ulrik Lassen & Hans Skovgaard Poulsen. (2018) Molecular profiling of short-term and long-term surviving patients identifies CD34 mRNA level as prognostic for glioblastoma survival. Journal of Neuro-Oncology 137:3, pages 533-542.
Crossref
Toni Rose Jue, Emily S. Sena, Malcolm R. Macleod, Kerrie L. McDonald & Theodore C. Hirst. (2018) A systematic review and meta-analysis of topoisomerase inhibition in pre-clinical glioma models. Oncotarget 9:13, pages 11387-11401.
Crossref
Mei Li, Xiangqi Song, Jun Zhu, Aijun Fu, Jianmin Li & Tong Chen. (2017) The interventional effect of new drugs combined with the Stupp protocol on glioblastoma: A network meta-analysis. Clinical Neurology and Neurosurgery 159, pages 6-12.
Crossref
Roberto Jose Diaz, Sheikh Ali, Mehreen Gull Qadir, Macarena I. De La Fuente, Michael E. Ivan & Ricardo J. Komotar. (2017) The role of bevacizumab in the treatment of glioblastoma. Journal of Neuro-Oncology 133:3, pages 455-467.
Crossref
Daniel H. Schanne, Anca-L. Grosu & Dan G. Duda. 2017. Tumor Angiogenesis. Tumor Angiogenesis 1 10 .
Theodore Nicolaides, Biljana Horn & Anuradha Banerjee. 2017. Pediatric CNS Tumors. Pediatric CNS Tumors 317 342 .
Hayato Nakamura, Yukihiro Yokoyama, Keisuke Uehara, Toshio Kokuryo, Junpei Yamaguchi, Toyonori Tsuzuki & Masato Nagino. (2016) The effects of bevacizumab on intestinal anastomotic healing in rabbits. Surgery Today 46:12, pages 1456-1463.
Crossref
Jiahao Su, Meiqin Cai, Wensheng Li, Bo Hou, Haiyong He, Cong Ling, Tengchao Huang, Huijiao Liu & Ying Guo. (2016) Molecularly Targeted Drugs Plus Radiotherapy and Temozolomide Treatment for Newly Diagnosed Glioblastoma: A Meta-Analysis and Systematic Review. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 24:2, pages 117-128.
Crossref
Carmen Balana, Ramon De Las Penas, Juan Manuel Sepúlveda, Miguel J. Gil-Gil, Raquel Luque, Oscar Gallego, Cristina Carrato, Carolina Sanz, Gaspar Reynes, Ana Herrero, Jose Luis Ramirez, Pedro Pérez-Segura, Alfonso Berrocal, Jose Maria Vieitez, Almudena Garcia, Sergio Vazquez-Estevez, Sergi Peralta, Isaura Fernandez, Ivan Henriquez, Maria Martinez-Garcia, Juan Jose De la Cruz, Jaume Capellades, Pilar Giner & Salvador Villà. (2016) Bevacizumab and temozolomide versus temozolomide alone as neoadjuvant treatment in unresected glioblastoma: the GENOM 009 randomized phase II trial. Journal of Neuro-Oncology 127:3, pages 569-579.
Crossref
L.Burt Nabors, Birgit Surboeck & Wolfgang Grisold. 2016. Gliomas. Gliomas 235 250 .
Jaime Gállego Pérez-Larraya & François Ducray. (2014) Treating glioblastoma patients with poor performance status: where do we go from here?. CNS Oncology 3:3, pages 231-241.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.